Is DuPont de Nemours Stock Outperforming the Dow?

Barchart
Apri Barchart
Is DuPont de Nemours Stock Outperforming the Dow?

Wilmington, Delaware-based DuPont de Nemours, Inc. (DD) provides technology-based materials and solutions. With a market cap of $17.3 billion, the company offers a diverse range of products, such as construction materials, adhesives, electronic, fabrics, fibers, home garden, medical devices, resins, printing, and consumer products.

Companies worth $10 billion or more are generally described as “large-cap stocks,” and DD perfectly fits that description, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the specialty chemicals industry. As a leader in materials science, DuPont is known for its legacy of innovation and high-quality products, giving it a competitive edge in the industry. With ongoing investments in research and development, DuPont is committed to staying ahead in the field of specialty chemicals and advanced materials.

More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.

 

Despite its notable strength, DD slipped 19.4% from its 52-week high of $157.98, achieved on Feb. 12. Over the past three months, DD stock has declined 5.8%, underperforming the Dow Jones Industrials Average’s ($DOWI4.3% gains during the same time frame.

www.barchart.com

Shares of DD have rose 5.6% on a YTD basis, underperforming DOWI’s YTD gains of 8.3%. However, in the longer term, the stock climbed 33.3% over the past 52 weeks, outperforming DOWI’s 14.5% returns over the same time frame.

To confirm the bearish trend, DD has been trading below its 200-day moving average since late August. The stock is trading below its 50-day moving average since early March, experiencing some fluctuations. 

www.barchart.com

DD’s strong outperformance has been fueled by strategic momentum across high-growth industries, including major expansion in municipal and industrial water treatment technologies, direct lithium extraction solutions, and specialized biopharma processing products, alongside resilient operational efficiency and strong market demand.

On Aug. 4, DD shares closed up more than 1% after reporting its Q2 results. Its revenue stood at $1.8 billion, up 4% year over year. The company’s adjusted EPS increased 48% from the year-ago quarter to $1.88. 

DD’s rival, PPG Industries, Inc. (PPG) lagged behind stock, with 2.5% gains in 2026 and a 3.4% downtick over the past 52 weeks.

Wall Street analysts are bullish on DD’s prospects. The stock has a consensus “Strong Buy” rating from the 16 analysts covering it, and the mean price target of $167.44 suggests a potential upside of 31.5% from current price levels. 


On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.

 

More news from Barchart

S&P Futures Climb as Oil Retreats Ahead of Key U.S. Inflation Data; Oracle Jumps After Earnings This High-Yield Advertising REIT Just Raised Its Dividend by More Than 3% Ahead of Kroger Earnings, Here's What Barchart Data Says Comes Next for KR Stock This Analyst Just Downgraded Uber Stock. Here's Why.